Why testosterone levels drop and when to consider treatment
Don't count on daily aspirin to prevent colon cancer
Night owls' habits linked to worse heart health
After ablation, exercise may lower atrial fibrillation recurrence
What can cause an enlarged heart?
Women's unique risks for heart disease
Chronic kidney disease: A hidden threat to your heart
Navigating your online patient portal: Best practices
Treating hair loss in men: What works?
Virtual cardiac rehab: Heal your heart from home
Diseases & Conditions Archive
Articles
A new approach to peripheral artery disease
A 2025 randomized controlled trial found that GLP-1 receptor agonists, the blockbuster drugs approved to treat diabetes and obesity, boosted the walking ability of people with diabetes and peripheral artery disease (PAD) in the legs. The news is encouraging, since there are few effective treatments for PAD-reduced blood flow in the limbs that leads to pain with activity. However, it will take more evidence before doctors feel comfortable prescribing GLP-1s if a person only has PAD.
Why testosterone levels drop and when to consider treatment
Don't count on daily aspirin to prevent colon cancer
Night owls' habits linked to worse heart health
After ablation, exercise may lower atrial fibrillation recurrence
What can cause an enlarged heart?
Women's unique risks for heart disease
Chronic kidney disease: A hidden threat to your heart
Navigating your online patient portal: Best practices
Treating hair loss in men: What works?
Virtual cardiac rehab: Heal your heart from home
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up
